VAISHALI PHARMA
Back to Balance Sheet
|
VAISHALI PHARMA Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹6.16 Cr | ₹3.17 Cr | ₹4.30 Cr | ₹4.28 Cr | ₹4.76 Cr |
What is the latest Total Non-Current Liabilities ratio of VAISHALI PHARMA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2023 | ₹6.16 Cr |
Mar2022 | ₹3.17 Cr |
Mar2021 | ₹4.30 Cr |
Mar2020 | ₹4.28 Cr |
Mar2019 | ₹4.76 Cr |
How is Total Non-Current Liabilities of VAISHALI PHARMA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹6.16 Cr | 94.04 | |
Mar2022 | ₹3.17 Cr | -26.16 | |
Mar2021 | ₹4.30 Cr | 0.30 | |
Mar2020 | ₹4.28 Cr | -10.10 | |
Mar2019 | ₹4.76 Cr | - |
Compare Total Non-Current Liabilities of peers of VAISHALI PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VAISHALI PHARMA | ₹176.8 Cr | 4.2% | 11.8% | 9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,026.0 Cr | 0.5% | -5.7% | 55.1% | Stock Analytics | |
CIPLA | ₹114,925.0 Cr | 1.1% | -4.4% | 55.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,128.0 Cr | -0.7% | 9.4% | 21.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,109.0 Cr | 0.1% | 1.1% | 28.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,736.0 Cr | 6% | 2.8% | 93.1% | Stock Analytics |
VAISHALI PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VAISHALI PHARMA | 4.2% |
11.8% |
9% |
SENSEX | 0.2% |
-0.2% |
20.9% |
You may also like the below Video Courses